Biosimilars in Turkey, MENA and Russia

September 5, 2012 7:08 AM

Informa Life Sciences is organizing Biosimilars in Turkey, MENA and Russia Conference in Istanbul, Turkey between 19-21 November, 2012. 

The key reasons to attend are:

• Implement successful strategies for registering biosimilars in Jordan, Egypt, Saudi Arabia, UAE and Russia with practical examples discussed from Julphar, Sandoz, JPM, Biocad and critical guideline updates from the Jordanian FDA
• Hear how Nobel successfully bought the first biosimilar to Turkey
• Compare and contrast biosimilar development in regulated and non-regulated markets with critical insight into the EMA and FDA biosimilar Guidelines
• Understand the do’s and don’ts of biosimilar development from industry leaders Celltrion and Sandoz
• Implement successful pricing & reimbursement strategies in the MENA regions with advice from Novartis and the Egyptian Ministry of Health

If you want to attend this conference, you can find more information here: www.informa-ls.com/biosimilarsMENA

Would you like to post an event on Biosimilar News?

 

Comments are closed

Share an Article?

Writing an article is not only a great way to share your knowledge, but it is also a great way to give back to the community.

We value all our contributors and if you have a website, we will surely give a link back to your site and products.
Wanna contribute?

Suggestions?

Biosimilar News was started for the people who are interested in this rapidly growing business area. So if you have suggestions or feedback on how we can improve, please let us know. If you want to see a specific topic covered, answer to a specific question, or anything else of this sort, just write us. We do our best to keep up!
Make a suggestion now!